Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohort
Fabian Jost-Brinkmann, Münevver Demir, Alexander Wree, Tom Luedde, Sven H. Loosen, Tobias Müller, Frank Tacke, Christoph Roderburg, Raphael Mohr
Research output: Contribution to journal › Article › peer-review
25Scopus
citations
Fingerprint
Dive into the research topics of 'Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohort'. Together they form a unique fingerprint.